The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.

The global Breast Biopsy Devices Market is projected to be valued at USD 2.47 billion in 2025 and is expected to reach USD 4.21 billion by 2035, registering a CAGR of 5.5% during the forecast period.

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform.